Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 19/20 | 0.65 |
| ▸ | NR1I2 | O75469 | 4/20 | 0.64 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.64 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3134641 | 0.84 | CACNA1B (0.65) | CACNA1BNR1I2CYP3A4DDR1 | |
| SCHEMBL3031561 | 0.83 | CACNA1B (0.82) | CACNA1BNR1I2CYP3A4DDR1 | |
| SCHEMBL3035326 | 0.80 | CACNA1B (0.77) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3125673 | 0.80 | CACNA1B (0.42) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3025680 | 0.80 | CACNA1B (0.73) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3138762 | 0.80 | CACNA1B (0.76) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3036818 | 0.78 | CACNA1B (1.00) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3025687 | 0.78 | CACNA1B (0.73) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3126273 | 0.77 | CACNA1B (0.58) | CACNA1BNR1I2CYP3A4 | |
| SCHEMBL3025693 | 0.73 | CACNA1B (0.62) | CACNA1BNR1I2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2205083-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2010-07-14 | — | — | EP | claimed |
| WO-2009045382-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2009-04-09 | — | — | WO | claimed |
| EP-2205083-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | Merck Sharp & Dohme Corp. (US) | 2010-07-14 | — | — | EP | disclosed |
| WO-2009045382-A1 | SUBSTITUTED ARYL SULFONE DERIVATIVES AS CALCIUM CHANNEL BLOCKERS | MERCK & CO., INC. (US) | 2009-04-09 | — | — | WO | disclosed |